Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

European Research Council grant · Running

FibroRevert Modeling and targeting cell-extracellular matrix communication to revert tissue fibrosis

Coordinator
I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do Porto, Portugal
Runs
1 July 2026 to 30 June 2031
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101221669

What the project is doing

In the project's own words, from its summary on CORDIS.

Skin fibrosis is a complex disorder characterized by the replacement of healthy tissue by pathological extracellular matrix (ECM). Despite its significant health burden, current treatments remain largely ineffective, leaving patients without efficient therapies. This gap is due to a limited understanding of how ECM cues and cells of the fibrotic niche co-evolve and interact over time to drive fibrosis. To address this, we will dissect how space- and time-dependent changes in ECM properties during fibrotic remodelling drive dysfunctional alterations in cell-matrix communication, thus promoting fibrosis progression.

To tackle this, we propose a multidisciplinary approach merging patient samples, bioinspired hydrogels, human cells, 3D bioprinting, and high-content analysis of fibrosis at cellular, molecular and tissue levels. With this patient-centred approach, we will create a modular hydrogel library with tissue-specific and programmable properties to uncover the role of ECM cues in fibrosis. By harnessing these new insights, we will capitalize on bioprinting to create unique 3D models recreating the heterogeneity and cell dynamics in human skin fibrosis to unveil tractable targets for therapeutic purposes.

Overall, this high-impact project addresses a major health challenge – identify drivers of fibrosis – leading to the development of innovative 3D models for discovering therapeutics that ultimately reverse fibrosis without disturbing tissue homeostasis.

Topics

Who is involved

OrganisationCityCountryRole
I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do PortoPortoPortugalCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI